Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus

Molecular and Cellular Biochemistry

Volumn 309, Issue 1-2, 2008, Pages 191-197

  Zhou, Hou De ^a,b   Li, Xiao Ling ^a   Li, Gui Yuan ^a   Zhou, Ming ^a   Liu, Hua Ying ^a   Yang, Yi Xing ^a   Deng, Tan ^a   Ma, Jian ^a   Sheng, Shou Rong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Epstein Barr virus; Innate immunity; Lipopolysaccharide; Oncogenicity; SPLUNC1 PLUNC

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GLYCOPROTEIN; GLYCOPROTEIN GP 220; GLYCOPROTEIN GP 350; LATENT MEMBRANE PROTEIN 1; PROTEIN SPLUNC1; SECRETORY PROTEIN; SHORT PALATE LUNG AND NASAL EPITHELIUM CLONE 1 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BACTERIAL GROWTH; CELL DISRUPTION; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC ANALYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; INNATE IMMUNITY; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; UPREGULATION; VIRUS CARCINOGENESIS; VIRUS CULTURE; VIRUS INHIBITION;

APOPTOSIS; B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; COLONY COUNT, MICROBIAL; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GLYCOPROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; LIPOPOLYSACCHARIDES; PHOSPHOPROTEINS; PSEUDOMONAS AERUGINOSA; RECOMBINANT PROTEINS; VIRAL MATRIX PROTEINS;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 4; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 38649121475     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9659-3     Document Type: Article

References (22)

1. Zhang B, Nie X, Xiao B et al (2003) Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer 38:80-90
2. Zhou HD, Fan SQ, Zhao J et al (2006) Tissue distribution of the secretory protein, SPLUNC1, in the human fetus. Histochem Cell Biol 125:315-324
3. LeClair EE (2003) Four reasons to consider a novel class of innate immune molecules in the oral epithelium. J Dent Res 82:944-950
4. Gazzano-Santoro H, Meszaros K, Birr C et al (1994) Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. Infect Immun 62:1185-1191
5. Zhou HD, Li GY, Yang YX et al (2006) Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE-1 cells depended on the bactericidal permeability increasing protein domain. Mol Immun 43:1864-1871
6. Bingle CD, Craven CJ (2002) LUNC: A novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum Mol Genet 11:937-943
7. Chu HW, Thaikoottathil J, Rino JG et al (2007) Function and regulation of SPLUNC1 protein in mycoplasma infection and allergic inflammation. J Immunol 179:3995-4002
8. He Y, Zhou G, Zhai Y et al (2005) Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J Med Genet 42:172-176
9. Chien YC, Chen JY, Liu MY et al (2001) Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345:1877-1882
10. Young LS, Murray PG (2003) Epstein-Barr virus and oncogenesis: From latent genes to tumours. Oncogene 22:5108-5121
11. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757-768
12. Curran JA, Laverty FS, Campbell D et al (2001) Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis. Cancer Res 61:6730-6738
13. Jung S, Chung YK, Chang SH et al (2001) DNA-mediated immunization of glycoprotein 350 of Epstein-Barr virus induces the effective humoral and cellular immune responses against the antigen. Mol Cells 12:41-49
14. Shannon-Lowe CD, Neuhierl B, Baldwin G et al (2006) Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 103:7065-7070
15. Thorley-Lawson DA, Schooley RT, Bhan AK et al (1982) Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell 30:415-425
16. Wagner BA, Buettner GR, Oberley LW et al (1998) Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species. Cancer Res 58:2809-2816
17. Ghafouri B, Kihlstrom E, Tagesson C et al (2004) PLUNC in human nasal lavage fluid: Multiple isoforms that bind to lipopolysaccharide. Biochim Biophys Acta 1699:57-63
18. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148
19. Sugden B (2002) In the beginning: A viral origin exploits the cell. Trends Biochem Sci 27:1-3
20. Hessell AJ, Hangartner L, Hunter M et al (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449:101-104
21. Gutierrez MI, Judde JG, Magrath IT et al (1996) Switching viral latency to viral lysis: A novel therapeutic approach for Epstein-Barr virus-associated neoplasia. Cancer Res 56:969-972
22. Mainou BA, Raab-Traub N (2006) LMP1 strain variants: Biological and molecular properties. J Virol 80:6458-6468